Lisa H. Butterfield
University of Pittsburgh
Hillman Cancer Center
5117 Centre Avenue
Pittsburgh
USA
Name/email consistency: high
- The Immunotherapeutics & Vaccine Summit--CHI's fourth annual meeting. Preclinical/clinical development of immunotherapies and vaccines. 17-19 August 2009, Providence, RI, USA. Butterfield, L.H. IDrugs (2009)
- Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma. Butterfield, L.H., Comin-Anduix, B., Vujanovic, L., Lee, Y., Dissette, V.B., Yang, J.Q., Vu, H.T., Seja, E., Oseguera, D.K., Potter, D.M., Glaspy, J.A., Economou, J.S., Ribas, A. J. Immunother. (2008)
- A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers". Butterfield, L.H., Disis, M.L., Fox, B.A., Lee, P.P., Khleif, S.N., Thurin, M., Trinchieri, G., Wang, E., Wigginton, J., Chaussabel, D., Coukos, G., Dhodapkar, M., Håkansson, L., Janetzki, S., Kleen, T.O., Kirkwood, J.M., Maccalli, C., Maecker, H., Maio, M., Malyguine, A., Masucci, G., Palucka, A.K., Potter, D.M., Ribas, A., Rivoltini, L., Schendel, D., Seliger, B., Selvan, S., Slingluff, C.L., Stroncek, D.F., Streicher, H., Wu, X., Zeskind, B., Zhao, Y., Zocca, M.B., Zwierzina, H., Marincola, F.M. J. Transl. Med (2008)
- Recent advances in immunotherapy for hepatocellular cancer. Butterfield, L.H. Swiss. Med. Wkly (2007)
- Immunotherapeutic strategies for hepatocellular carcinoma. Butterfield, L.H. Gastroenterology (2004)
- T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer. Butterfield, L.H., Ribas, A., Meng, W.S., Dissette, V.B., Amarnani, S., Vu, H.T., Seja, E., Todd, K., Glaspy, J.A., McBride, W.H., Economou, J.S. Clin. Cancer Res. (2003)